The National Authority of Medicines and Health Products (Autoridade Nacional do Medicamento e Produtos de Saúde or Infarmed) has ordered the withdrawal of a specific batch of Salofalk from the market. Patients currently using the medication for intestinal inflammation are advised not to interrupt their treatment without consulting their doctor.
Infarmed recalls batch of intestinal medication
Tuesday, 1 September 2026AI summary
Context & Explainers
Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde) is Portugal’s national regulator for medicines and health products that approves drugs, monitors safety and enforces rules on pricing and reimbursement. In 2025 it approved 928 new medicines — 79% were generics, 38 were designated essential and 236 were national products — which affects which medicines are available and how much they cost at pharmacies.
